Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2000
10/25/2000CN1271291A Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and use thereof
10/25/2000CN1271290A Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and use thereof
10/25/2000CN1271288A Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
10/25/2000CN1271287A New use of budesonide and formoterol
10/25/2000CN1271286A Coated dosage unit
10/25/2000CN1271282A Oral compositions of levosimendan
10/25/2000CN1271281A Medicamenet formulation with a controlled release of an active agent
10/25/2000CN1271280A A transdermal drug delivery system for anti-inflammatory analogesic agent comprising diclofenac diethylammonium, and the manufacturing method thereof
10/25/2000CN1271277A Biodegradable macromers fro the controlled release of biologically active substances
10/25/2000CN1271276A Controlled release of drugs delivered by sublingual or buccal administration
10/25/2000CN1271275A Small particle liposome aerosols for delivery of atni-cancer drugs
10/25/2000CN1271251A 2-methyl-thieno-benzodiazepine formulation
10/25/2000CN1270838A Adjuvant used in vaccine
10/25/2000CN1270836A Pain stopping ointment and its preparation
10/25/2000CN1270825A Chinese medicine for treading hepatitis A and B and its recipe
10/25/2000CN1270820A Tonic compound deer fetus ointment and its preparation
10/25/2000CN1270814A Cough and asthma relieving and phlegm eliminating capsule and its preparation
10/25/2000CN1270807A Forming method for low substituted degree hydroxy propyl cellulose particles
10/25/2000CN1270806A First and adhesive plaster
10/25/2000CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders
10/25/2000CN1057727C Compacted medicament supply for generating inhalable medicament particals
10/25/2000CN1057701C Health-care inlalant of loguat leaf and preparing method
10/25/2000CN1057699C Capsule for treating apoplexy sequela and its producing method
10/25/2000CN1057694C Plaster for treating hyperosteogeny and its prepn. method
10/25/2000CN1057684C Germicidal anti-inflammatory myogenic plaster for external use and preparation method thereof
10/25/2000CN1057673C Tablet, capsule, or granule comprising desogestrel
10/25/2000CN1057672C Medicine for curing cerebrovascular disease
10/25/2000CN1057671C Coated vitamin C preparation for animal feed, production and use thereof
10/25/2000CN1057670C Prolonged release preparation and polymers thereof
10/24/2000US6136864 Denaturants for sympathomimetic amine salts
10/24/2000US6136846 In water miscible solubilizer
10/24/2000US6136833 Pharmaceutical formulations and process for their preparation
10/24/2000US6136807 Mixture with acrylate polymers
10/24/2000US6136799 Cosolvent formulations
10/24/2000US6136793 Formulations containing hyaluronic acid
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136783 Antifungal compositions
10/24/2000US6136357 Anhydrous; cyclosporin; monoglycerides, diglycerides, and/or triglycerides of natural fatty acids; natural fatty acids and/or their alkaline salts; a substance containing 3-sn-phosphatidyl choline and/or phosphatidyl ethanolamine
10/24/2000US6136347 Drug as anhydrate of its base form microencapsulated in a coating of methyl or ethyl esters or quaternary ammonium compounds of polymethacrylic acid, or ethylcellulose, and triethyl citrate, optionally hydroxypropyl methyl cellulose
10/24/2000US6136346 Spray drying an aqueous mixture of an excipient, a dispersibility-enhancing, water soluble polypeptide and drug to obtain an aerosolizable powder for inhalation therapy having increased dispersibility due to the polypeptide
10/24/2000US6136345 Central core of amoxycillin(am) surrounded by a release retarding coating layer, and in a casing layer surrounding the core is am and clavulanate, initial quick release of am and clavulanate, and sustained release of am
10/24/2000US6136344 Oral pharmaceutical dosage form
10/24/2000US6136343 Excipient including a gelling agent, an inert pharmaceutical diluent, cationic crosslinking agent with said gelling agent that increases gel strength when dosage form exposed to environmental fluid, and a medicament having poor solubility
10/24/2000US6136338 Given dosage of difloxacin or salt thereof in inert carrier
10/24/2000US6136337 Comprises an acrylic acid polymer, a vasoconstrictor, and a rectal tissue-curing agent; suppository; for curing hemorrhoids or the like
10/24/2000US6136336 JM216 formulations
10/24/2000US6136335 Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity
10/24/2000US6136334 Aqueous medical device or vehicle useful for diagnostic or drug delivery, prevention of post-operative adhesions, or as protective corneal shield, comprising an ionic polysaccharide and film forming agent capable of in situ gelation
10/24/2000US6136332 Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils
10/24/2000US6136327 Stereospecific delivery of a drug using electrotransport
10/24/2000US6136316 Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection
10/24/2000US6136297 Delivery system for an oral care substance using a strip of material having low flexural stiffness
10/24/2000US6136295 Biocompatible particles for delivery of a therapeutic, prophylactic or diagnostic agent to the pulmonary system comprising a therapeutic, prophylactic or diagnostic agent
10/24/2000US6136294 Amino acid stabilized medical aerosol formulation
10/24/2000US6136293 Gas or air filled microbubble suspensions in aqueous phases usable as imaging contrast agents in ultrasonic echography
10/24/2000US6135628 Method and apparatus for homogenizing aerosol formulations
10/24/2000CA2211376C Bio-erodible ophthalmic shield
10/24/2000CA2194226C Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
10/24/2000CA2181810C Process for producing s(+)-ibuprofen particles
10/24/2000CA2179628C Psoriasis treatment
10/24/2000CA2161950C Subdermally implantable device
10/22/2000CA2306337A1 Cosmetic compound, namely make-up compound, containing a pigment derived from pyrrolopyrrole
10/19/2000WO2000061788A2 Poly(dipeptide) as a drug carrier
10/19/2000WO2000061766A2 Telomerase-specific cancer vaccine
10/19/2000WO2000061726A1 Composition for the preservation of infectious recombinant adenoviruses
10/19/2000WO2000061611A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
10/19/2000WO2000061595A1 The novel antisense-oligos with better stability and antisense effect
10/19/2000WO2000061543A2 Esters of l-carnitine or alkanoyl l-carnitines
10/19/2000WO2000061274A1 Method for coating and film-coating fine powders in a fluidised bed coating unit
10/19/2000WO2000061220A1 Iontophoresis device
10/19/2000WO2000061191A2 Heat stable coated colloidal iron oxides
10/19/2000WO2000061190A2 Treatment of intracellular infection
10/19/2000WO2000061189A2 Water-soluble compositions of bioactive lipophilic compounds
10/19/2000WO2000061184A2 Dry formulation for transcutaneous immunization
10/19/2000WO2000061178A1 Pulmonary administration of dry powder formulations for treating infertility
10/19/2000WO2000061174A2 Use of pegylated interferon alpha for renal cell carcinoma treatment
10/19/2000WO2000061170A2 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
10/19/2000WO2000061169A1 Pharmaceutical compositions of erythropoietin
10/19/2000WO2000061168A1 Ocular treatment using cyclosporin-a derivatives
10/19/2000WO2000061149A1 Long-acting antibacterial composition
10/19/2000WO2000061147A1 Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
10/19/2000WO2000061141A2 Methods and compositions for enhancing delivery of therapeutic agents to tissues
10/19/2000WO2000061130A1 Compounds useful in reducing the level of insulin like growth factor-1 (igf-1) in blood
10/19/2000WO2000061129A2 S-hydroxynefazodone
10/19/2000WO2000061120A1 Preparations for percutaneous absorption
10/19/2000WO2000061119A2 A process for the microencapsulation of medicaments
10/19/2000WO2000061118A1 Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition
10/19/2000WO2000061117A1 Fast-dispersing dosage forms containing fish gelatin
10/19/2000WO2000061116A2 Pharmaceutical formulation comprising amoxycillin and clavulanate
10/19/2000WO2000061115A2 Pharmaceutical formulation comprising amoxycillin
10/19/2000WO2000061114A1 Fine particles targeting cells and process for producing the same
10/19/2000WO2000061113A1 Lipid aggregate forming compositions and their uses
10/19/2000WO2000061112A2 Solubilized pharmaceutical composition for parenteral administration
10/19/2000WO2000061111A1 A pharmaceutical formulation comprising an bisphosphonate and an additive agent providing an enhanced absorption of the bisphosphonate
10/19/2000WO2000061110A1 Icecream-type pharmaceutical formulation and process for preparing the same
10/19/2000WO2000061109A1 Process for producing medicinal composition of basic hydrophobic medicinal compound
10/19/2000WO2000061106A1 Antimicrobial wipes which provide improved immediate germ reduction
10/19/2000WO2000061077A1 Liquid dispersion polymer compositions, their preparation and their use
10/19/2000WO2000061068A2 Anthelmintic compositions
10/19/2000WO2000060956A1 Hydrogel-forming system with hydrophobic and hydrophilic components
1 ... 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 ... 2991